United States Controlled Release Drug Delivery Market worth $101.3 billion by 2031 - Exclusive Report by DatamIntelligence

"The Global Controlled Release Drug Delivery Market reached USD 50.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 101.3 billion by 2031. The global controlled release drug delivery market is expected to exhibit a CAGR" As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/controlled-release-drug-delivery-market?sp

United States: Recent Industry Developments

✅ In September 2025, Johnson & Johnson launched a next-generation controlled release oral formulation for chronic pain management, providing steady therapeutic levels while reducing dosing frequency and improving patient adherence.

✅ In August 2025, Pfizer expanded its portfolio with injectable controlled release therapies for oncology, offering prolonged drug exposure and optimized pharmacokinetics for targeted tumor treatment.

✅ In July 2025, Amgen introduced biodegradable polymer-based drug delivery systems for biologics, enabling sustained release and enhanced therapeutic outcomes for autoimmune conditions.

✅ In June 2025, Eli Lilly invested in R&D for nano-formulated controlled release platforms, integrating precision dosing and improved bioavailability for cardiovascular and metabolic drugs.

Japan: Recent Industry Developments

✅ In September 2025, Takeda Pharmaceutical launched innovative oral controlled release formulations for gastrointestinal disorders, improving therapeutic consistency and patient compliance in Japan.

✅ In August 2025, Astellas Pharma expanded its controlled release injectable therapies for oncology and urology, optimizing drug exposure and minimizing adverse effects.

✅ In July 2025, Daiichi Sankyo introduced polymer-based drug delivery systems for sustained release of biologics, enhancing treatment efficacy and patient convenience.

✅ In June 2025, Chugai Pharmaceutical invested in R&D for advanced nanoparticle-controlled release platforms, supporting precision dosing and improved pharmacodynamics for chronic and complex diseases.

Controlled Release Drug Delivery Market: Drivers

The controlled release drug delivery market is witnessing significant growth, driven by increasing demand for advanced therapeutic systems that improve drug efficacy, safety, and patient compliance. Controlled release formulations enable precise drug delivery over extended periods, reducing dosing frequency, minimizing side effects, and optimizing pharmacokinetics for chronic and complex diseases. Advances in polymer science, nanotechnology, biodegradable implants, and smart delivery systems are enhancing the precision, targeting, and versatility of controlled release platforms. Growing prevalence of chronic diseases, rising geriatric populations, and increasing adoption of personalized medicine are further supporting market adoption. Expansion of pharmaceutical R&D, clinical trials, and regulatory approvals for innovative delivery systems is fueling demand for controlled release technologies.

Leading pharmaceutical and biotech companies, including Johnson & Johnson, Pfizer, Novartis, and Teva Pharmaceuticals, are investing in the development of advanced controlled release formulations, including oral, transdermal, injectable, and implantable systems. Research into stimulus-responsive, nanoparticle-based, and gene-targeted delivery platforms is expanding therapeutic possibilities. Strategic collaborations between drug manufacturers, research institutions, and technology providers are accelerating product innovation, clinical evaluation, and commercialization. Growing focus on improving patient adherence, reducing healthcare costs, and enhancing treatment outcomes is driving adoption across multiple therapeutic areas. With continuous technological advancements, rising chronic disease burden, and expanding R&D initiatives, the controlled release drug delivery market is poised for sustained global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/controlled-release-drug-delivery-market?sp

Controlled Release Drug Delivery Market: Major Players

Johnson and Johnson, Coating Place, Inc, Corium International, Inc, Depomed, Inc, Pfizer, Inc, Biogen, GlaxoSmithKline, Novartis, Orbis Biosciences, Inc., Merck and Co and among others.

Segment Covered in the Controlled Release Drug Delivery Market:

➥ By Product: Polymer-based Drug Delivery System, Micro Reservoir Partition-controlled Drug Delivery System, Feedback Regulated Drug Delivery System, Activation Modulated Drug Delivery System (Osmotic Pressure-activated Drug Delivery, Hydrodynamic Pressure-activated Drug Delivery, Vapor Pressure-activated Drug Delivery, Mechanically Activated Drug Delivery, Magnetically Activated Drug Delivery), Chemically Activated Drug Delivery System (pH Activated Drug Delivery, Hydrolysis Activated Drug Delivery, Enzyme Activated Drug Delivery)

➥ By Technology: Wurster Technique, Microencapsulation, Coacervation, Targeted Delivery

➥ By Route of Administration: Drug-eluting Stents, Ocular Implants, Nasal Sprays, Transdermal Patches,

Research Process:

Both primary and secondary data sources have been used in the Controlled Release Drug Delivery Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Controlled Release Drug Delivery Market Research Industry:

➠ Who leads the Controlled Release Drug Delivery industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Controlled Release Drug Delivery market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Controlled Release Drug Delivery market growth?
➠ What are the dominant sales and distribution strategies in the Controlled Release Drug Delivery industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=controlled-release-drug-delivery-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.